Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Actemra
Pharma
J&J nixes Tremfya trial in giant cell arteritis
Johnson & Johnson's Tremfya couldn't repeat the success of rival drugs from AbbVie and Roche in giant cell arteritis.
Fraiser Kansteiner
Jun 25, 2024 4:45pm
Roche, Biogen settle Actemra biosimilar lawsuit
Oct 25, 2023 10:20am
Takeda, Kyowa Kirin, Biogen—Fierce Pharma Asia
Oct 6, 2023 8:35am
Biogen nabs FDA nod for biosimilar of Roche blockbuster Actemra
Oct 2, 2023 10:42am
Roche sues Biogen over Actemra biosimilar infringement claims
Jul 17, 2023 9:45am
The top 10 drug patent expirations of 2023
Mar 13, 2023 3:00am
